Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65576 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Letermovir
CAS :<p>Applications Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems.<br>References Kropeit, D. et al.: Brit. J. Clin Pharmacol., 83, 2678 (2017); Kim, E. et al.: Drugs. 78, 147 (2018);<br></p>Formule :C29H28F4N4O4Couleur et forme :NeatMasse moléculaire :572.551GLPG-0634 (Filgotinib)
CAS :Produit contrôlé<p>Applications GLPG-0634 (Filgotinib) is a potent, selective JAK1 inhibitor. Used as an anti-inflammatory agent, it reduces levels of inflammatory cytokines in the bones and tissue of mammals.<br>References Moran, N. et al.: BioWorld Int., 16, 1 (2011);<br></p>Formule :C21H23N5O3SCouleur et forme :NeatMasse moléculaire :425.54-Bromo-1-(2-fluoro-benzyl)-3-nitro-1H-pyrazole
CAS :Formule :C10H7BrFN3O2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :300.0874-Nitrophenyl 5-chlorothiophene-2-carboxylate
CAS :Degré de pureté :95.0%Masse moléculaire :283.67999267578125Carvedilol N’-2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amine
CAS :Produit contrôlé<p>Impurity Carvedilol Impurity A; Carvedilol USP A<br>Applications An impurity from the process of Carvedilol (C184625). Carvedilol impurity A. Carvedilol USP A.<br></p>Formule :C36H43N3O7Couleur et forme :NeatMasse moléculaire :629.74Deferiprone 3-O-β-D-Glucuronide Sodium Salt
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications A metabolite of Deferiprone (D474000).<br>References Choudhury, R., et al.: Drug Metab. Dispos., 23, 314 (1995),<br></p>Formule :C13H16NNaO8Couleur et forme :Yellow To Dark YellowMasse moléculaire :337.262-(2-nitrophenyl)-1,4-dihydroquinazolin-4-one
CAS :Degré de pureté :95%Masse moléculaire :267.24398803710941,4-bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
CAS :Produit contrôlé<p>Impurity Aripiprazole Diquinoline Butanediol Impurity (USP)<br>Applications An impurity found in the process for the preparation of Aripiprazole (A771000). Aripiprazole Diquinoline Butanediol Impurity (USP).<br>References Burris, K., et al.: J. Pharmacol. Exp. Ther., 302, 381 (2002), Harrison, T., et al.: Drugs, 64, 1715 (2004),<br></p>Formule :C22H24N2O4Couleur et forme :Off-WhiteMasse moléculaire :380.44Ethyl 4-iodo-1,5-dimethyl-1H-pyrazole-3-carboxylate
CAS :Degré de pureté :98%Masse moléculaire :294.0920104980469Dehydronitroso Nifedipine
CAS :Produit contrôlé<p>Impurity Nifedipine EP Impurity B<br>Applications A photodegradation product of Nifedipine (N457000). Shown to relax contractions of the rat aortic strip induced by norepinephrine and other agonists.<br>References Hayase, N. et at.: J. Pharmac. Exp. Ther., 275, 813 (1995); De Vries, H. et al.: Photochem. Photobio., 62, 959 (1995);<br></p>Formule :C17H16N2O5Couleur et forme :NeatMasse moléculaire :328.325-tert-Butyl-1-(4-nitro-phenyl)-1H-pyrazole-3-carboxylic acid
CAS :Formule :C14H15N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :289.291Amantadine-d15 Hydrochloride
CAS :Produit contrôlé<p>Applications NMDA-receptor antagonist. Antiviral; antiparkinsonian.<br>References Vernier, V.G., et al; Toxicol. Appl. Pharmacol., 15, 642 (1969), Kirschbaum, J., et al.: Anal. Profiles Drug Subs., 12, 1 (1983),<br></p>Formule :C102H15H2NCouleur et forme :NeatMasse moléculaire :166.34Axitinib Iodo Tetrahydropyran
Produit contrôlé<p>Applications Axitinib Iodo Tetrahydropyran is an analog of Axitinib (A794650). Axitinib (A794650) is a tyrosine kinase inhibitor. Axitinib is used in cancer therapy.<br>References Wasser, K., et al.: Eur. Radiol., 13, 80 (2003);Park, J., et al.: Clin. Cancer Res., 8, 1172 (2002); Bergers, G., et al.: J. Clin. Invest., 111, 1287 (2003);<br></p>Formule :C19H20IN3OCouleur et forme :NeatMasse moléculaire :433.286Phenyl-(3-phenyl-quinoxalin-2-yl)-methanone
CAS :Degré de pureté :95.0%Masse moléculaire :310.35598754882813-[(4-Fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoic Acid
CAS :Produit contrôlé<p>Impurity Bicalutamide EP Impurity M<br>Applications 3-[(4-Fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoic Acid is an impurity of Bicalutamide (B382000); a non-steroidal peripherally active antiandrogen. Also used as an antineoplastic (hormonal).<br>References Tucker, H., et al.: J. Med. Chem., 31, 954 (1988); Cockshott, I.D., et al.: Eur. Urol., 18, Suppl. 3, 10 (1990); Cockshott, I., et al.: Br. J. Clin. Pharm., 36, 339 (1993); McKillop, D., et al.: Xenobiotica, 25, 623 (1995)<br></p>Formule :C10H11FO5SCouleur et forme :NeatMasse moléculaire :262.25Lercanidipine-d3 Hydrochloride
CAS :Produit contrôléFormule :C36D3H38N3O6·HClCouleur et forme :NeatMasse moléculaire :651.21Ondansetron
CAS :Produit contrôlé<p>Applications Ondansetron is a specific serotonin (5-HT3) receptor antagonist. Antiemetic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kris, M.G., et al.: J. Clin. Oncol., 6, 659 (1988); Faris, P..L., et al.: Lances, 355, 792 (2000)<br></p>Formule :C18H19N3OCouleur et forme :White To Light BeigeMasse moléculaire :293.363,6-Bis(5-bromothiophen-2-yl)-2,5-dioctylpyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione
CAS :Degré de pureté :95%Masse moléculaire :682.57000732421883-phenylquinoline-2,4-dicarboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :293.27801513671875(-)-trans-Phenothrin
CAS :<p>Applications (-)-trans-Phenothrin is used in exhaustive parallel conformational search of pyrethroids and structural similarity study. Also used as an active compound combination having insecticidal properties, a synthetic reagent in the preparation and optical purity of benzylic ester pyrethroid enantiomers.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Bertok, B., et al.: J. Environ. Sci. Health, Part B., 31, 495 (1996); Chuman, H., et al.: Journal of Chemical Software, 4, 143 (1998); Thielert, W., et al.: PCT Int. Appl. (2015), WO 2015132140 A1 20150911;<br></p>Formule :C23H26O3Couleur et forme :Colourless To YellowMasse moléculaire :350.45Chlorambucil 2-Chloroethyl Ester
CAS :Produit contrôlé<p>Applications Chlorambucil 2-Chloroethyl Ester is a derivative of Chlorambucil (C325050); an alkylating agent that is used as a chemotherapy drug in the treatment of chronic lymphocytic leukemia.<br>References Cogia, A., et al.: Leuk. Lymph., 53, 1961 (2012); Tonino, S.H., et al.: Leuk. Lymph., 53, 1785 (2012); Smolej, L., et al.: Curr. Pharma. Design., 18, 3399 (2012)<br></p>Formule :C16H22Cl3NO2Couleur et forme :NeatMasse moléculaire :366.712-(2-Nitrobenzylidene)-3-oxobutanoic Acid, Methyl Ester
CAS :Produit contrôlé<p>Applications 2-(2-Nitrobenzylidene)-3-oxobutanoic Acid, Methyl Ester (cas# 39562-27-1) is a compound useful in organic synthesis.<br></p>Formule :C12H11NO5Couleur et forme :NeatMasse moléculaire :249.222-(4-Chlorophenoxy)aniline
CAS :Produit contrôlé<p>Applications Amoxapine impurity.<br>References Matsuo, M., et al.: Chem. Pharma. Bull., 33, 4409 (1985),<br></p>Formule :C12H10ClNOCouleur et forme :NeatMasse moléculaire :219.67Salbutamol Glyoxal Impurity
Produit contrôlé<p>Stability Hygroscopic<br>Applications Salbutamol Glyoxal Impurity that is synthesized from C369215 (3-Chloromethyl-4-hydroxyacetophenone).<br></p>Formule :C9H10O5Couleur et forme :Off White SolidMasse moléculaire :198.175-Aminoisoquinoline-3-carboxylic acid
CAS :Degré de pureté :95+%Masse moléculaire :188.186004638671885-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
CAS :Degré de pureté :97.0%Masse moléculaire :370.4200134277344Ref: 10-F540283
1gÀ demander2mg79,00€5mg128,00€10mg94,00€25mg120,00€50mg227,00€100mg412,00€250mgÀ demander(trans)-4-Morpholin-4-yl-cyclohexylamine; dihydrochloride
CAS :Degré de pureté :%Masse moléculaire :184.157563264-(furan-2-yl)-6-(5-methylthiophen-2-yl)pyrimidin-2-amine
CAS :Degré de pureté :95.0%Masse moléculaire :257.30999755859375(2R,3S)-rel-Nadolol-de(N-tert-butyl)methoxy
<p>Impurity Nadolol EP Impurity B<br>Stability Hygroscopic<br>Applications (2R,3S)-rel-Nadolol-de(N-tert-butyl)methoxy is an impurity of Nadolol (N201050), a β-Adrenergic blocker. Antihypertensive; antianginal.<br>References Dreyfuss, J., et al.: J. Clin. Pharmacol., 17, 300 (1977); Sibley, P.L., et al.: Toxicol. Appl. Pharmacol., 44, 379 (1978); Slusarek, L., et al.: Anal. Profiles Drug Subs., 9, 455 (1980)<br></p>Formule :C14H20O5Couleur et forme :NeatMasse moléculaire :268.304-phenyl-2-hydrophthalazin-1-one, 98%
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :222.2469940185547Decloxizine Dihydrochloride
CAS :Produit contrôlé<p>Impurity Hydroxyzine EP Impurity B<br>Applications Decloxizine Dihydrochloride (Hydroxyzine EP Impurity B) is a Hydroxyzine (H996500) impurity.<br>References Lulling, J., et al.: Medicina Pharmacol. Exp., 16 48 (1967),<br></p>Formule :C21H28N2O2·2ClHCouleur et forme :NeatMasse moléculaire :413.384-(3-methylthiophen-2-yl)-6-(thiophen-2-yl)pyrimidin-2-amine
CAS :Degré de pureté :95.0%Masse moléculaire :273.3699951171875Oxyphenbutazone-d9
CAS :Produit contrôléFormule :C192H9H11N2O3Couleur et forme :BeigeMasse moléculaire :333.43Mirtazapine-d4
CAS :Produit contrôlé<p>Applications Mirtazapine-d4 is the labeled analogue of Mirtazapine (M365000), which is an α2-Adrenergic blocker, analogue of Mianserin, and antidepressant.<br>References De Boer, T., et al.: Neuropharmacology, 27, 399 (1988), Smith, W.T., et al.: Psychopharmacol. Bull., 26, 191 (1990);<br></p>Formule :C17H15D4N3Couleur et forme :White To Light YellowMasse moléculaire :269.381-(2,4-Dichloro-benzyl)-1 H -pyrazol-3-ylamine
CAS :Formule :C10H9Cl2N3Couleur et forme :SolidMasse moléculaire :242.1Axitinib Sulfoxide
CAS :Produit contrôléFormule :C22H18N4O2SCouleur et forme :NeatMasse moléculaire :402.47Tert-Butyl 1-oxo-4-(pyridin-3-yl)-2,8-diazaspiro[4.5]decane-8-carboxylate
CAS :Degré de pureté :98%Masse moléculaire :331.41598510742192-Methylamino-1-morpholin-4-yl-ethanonehydrochloride
CAS :Degré de pureté :98.0%Couleur et forme :SolidMasse moléculaire :194.66000366210938N-Demethyl Ondansetron
CAS :<p>Applications A metabolite of Ondansetron (O655000).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Bayliss, M., et al: Xenobiotica, 24, 231 (1994), Atkins, W., et al.: J. Biol. Chem., 277, 33258 (2002), De Graaf, I., et al.: Drug Metab. Dispos., 30, 1129 (2002),<br></p>Formule :C17H17N3OCouleur et forme :White To BrownMasse moléculaire :279.346-Hydroxy-2-mercaptobenzimidazole
CAS :Produit contrôléFormule :C7H6N2OSCouleur et forme :NeatMasse moléculaire :166.20Indigo Carmine
CAS :Produit contrôlé<p>Stability Light Sensitive<br>Applications Indigo carmine is a dye consisting of an indigo dimer with sodium salts of sulfonic acids at positions 5 and 5'. This compound has been used as a tissue stain, pH indicator, and tool for the determination of hypochlorite in solutions.<br>References 1. Reinle, G.G. and Depuy, E.S. 1920. Cal State J Med. 18: 49-52. PMID: 187381042. Monson, F.C., et al. 1991. J. Urol. 145: 842-845. PMID: 20057163. Harriram, A., et al. 2003. J Environ Sci Health A Tox Hazard Subst Environ Eng. 3: 1055-1064. PMID: 127749084. Archer, T.L. 2009. J Clin Anesth. 21: 544-546. PMID: 200062695. Lee, B.E., et al. 2010. BMC Gastroenterol. 10 97. PMID: 207318306. Park, H.J., et al. 2010. J Clin Ultrasound. 38: 305-308. PMID: 20544866<br></p>Formule :C16H8N2O8S2·2NaCouleur et forme :NeatMasse moléculaire :466.351-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :295.24200439453125Tolcapone
CAS :Produit contrôlé<p>Applications Orally active inhibitor of central and peripheral catechol-O-methyltransferase (COMT). Antiparkinsonian.<br>References Dingemanse, J., et al.: Clin. Pharmacol. Ther., 57, 508 (1995), Keating, K.A., Drugs, 19, 165 (2005),<br></p>Formule :C14H11NO5Couleur et forme :ColourlessMasse moléculaire :273.24Sitagliptin Monohydrochloride Monohydrate
CAS :<p>Applications Sitagliptin Monohydrochloride Monohydrate has therapeutic applications and is used in pharmaceutical compositions in the form of immediate release tablets.<br>References Arroyo Hidalgo, S., & Pladevall Roses, M.: PCT Int. Appl. (2015), WO 2015114152 A1<br></p>Formule :C16H15F6N5O·HCl·H2OCouleur et forme :NeatMasse moléculaire :407.31 + 36.46 + 18.026,7-Dimethyl-3-phenyl-quinoxaline-2-carboxylic acid ethyl ester
Degré de pureté :95.0%Masse moléculaire :306.3649902343752,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]
CAS :Produit contrôlé<p>Applications An impurity in the synthesis of Silodosin (S465000), an α1a-adrenoceptor antagonist. It is used in treatment of benign prostatic hypertophy.<br>References Barve, I. et al.: Tetra., 69, 2834 (2013); Shibata, K., et al.: Mol. Pharmacol., 48, 250 (1995), Murata, S., et al.: J. Urol., 164, 578 (2000),<br></p>Formule :C25H30F3N3O3Couleur et forme :Light YellowMasse moléculaire :477.523,4-Dihydro-7-hydroxyquinoline-2(1H)-one
CAS :Formule :C9H9NO2Couleur et forme :NeatMasse moléculaire :163.176,7-DIMETHOXY-2-METHYL-4-(PIPERAZIN-1-YL)QUINAZOLINE
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :288.351013183593753-Hydroxy Ropivacaine
CAS :Produit contrôlé<p>Applications A major metabolite of Ropivacaine (R675000).<br>References Ekstrom, G., et al.: Drug Metab. Dispos., 24, 955 (1996), Arvidsson, T., et al.: Biomed. Chromatogr., 13, 286 (1999), Shah, V., et al.: Pharm. Res., 17, 1551 (2000),<br></p>Formule :C17H26N2O2Couleur et forme :NeatMasse moléculaire :290.4[1-(2-Thienyl)-3,4-dihydroisoquinolin-2(1H)-yl]acetic acid
CAS :Degré de pureté :95.0%Masse moléculaire :273.3500061035156Haloperidol-d4
CAS :Produit contrôlé<p>Applications Antidyskinetic; antipsychotic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980), Beresford, R., et al.: Drugs, 33, 31 (1987)<br></p>Formule :C212H4H19ClFNO2Couleur et forme :WhiteMasse moléculaire :379.893’-Anhydro Ezetimibe
CAS :Produit contrôléFormule :C24H19F2NO2Couleur et forme :NeatMasse moléculaire :391.41Uvinul A Plus
CAS :<p>Applications Uvinul A Plus is a component of cosmetic emulsion with UV protection.<br>References Chang, M., et al.: J. Food Drug Anal., 9, 199 (2001), Simeoni, S., et al.: J. Pharm. Biomed. Anal., 38, 250 (2005), Vielhaber, G., et al.: Photochem. Photobiol. Sci., 5, 275 (2006), Lee, S., et al.: J. Cosmet. Sci., 59, 469 (2008),<br></p>Formule :C24H31NO4Couleur et forme :White To YellowMasse moléculaire :397.51Anastrozole
CAS :Produit contrôlé<p>Applications An aromatase inhibitor. Used as an antineoplastic.<br>References Plourde, P.V., et al.: Breast Cancer Res. Treat., 30, 103 (1994), Buzdar, A.U., et al.: Cancer, 79, 730 (1997)<br></p>Formule :C17H19N5Couleur et forme :NeatMasse moléculaire :293.37R-(-)-Deprenyl Hydrochloride
CAS :Produit contrôlé<p>Applications Monoamine oxidase-B inhibitor related structurally to Pargyline. Used to alleviate the symptoms of Parkinsons disease.<br>References Magyar, K., et al.: Acta Physiol. Acad. Sci. Hung., 32, 377 (1967), Heinonen, E.H., et al.: Acta Neurol. Scand., 84, 44 (1991), Schneider, L.S., et al.: Am. J. Psychiatry, 150, 321 (1993),<br></p>Formule :C13H17N·ClHCouleur et forme :White To Off-WhiteMasse moléculaire :223.74N4-(3-Chloro-4-fluorophenyl)-7-ethoxyquinazoline-4,6-diamine (Afatinib Impurity)
CAS :Degré de pureté :97%Masse moléculaire :332.763,4-Dimethoxybenzoic Acid (Veratric Acid)
CAS :Produit contrôlé<p>Applications Veratric Acid is a derivative of Protocatechuic Acid. Veratric Acid is a reagent used in the production of antimicrobial agents, antifeedants, and a variety of other biologically active compounds.<br>References Alissandrakis, E., et al.: Eur. Food Res. Technol., 229, 365 (2009), Spaccini, R., et al.: Soil Biol. Biochem., 41, 1164 (2009), Narasimhan, B., et al.: Eur. J. Med. Chem., 44, 689 (2009), Pereira, L., et al.: J. Biotechnol., 139, 68 (2009),<br></p>Formule :C9H10O4Couleur et forme :NeatMasse moléculaire :182.17O-Desisopropyl-O-methoxyethyl Nimodipine
CAS :Produit contrôlé<p>Impurity Nimodipine EP Impurity C; Nimodipine USP Related Compound B<br>Applications O-Desisopropyl-O-methoxyethyl Nimodipine (Nimodipine EP Impurity C) is an impurity in the synthesis of Nimodipine (A dihydropyridine calcium channel blocker. It is used as a vasodilator (cerebral). Nimodipine USP Related Compound B.<br>References Allen, G.S., et al.: N. Engl. J. Med., 308, 619 (1983), Schluter, H.: Arzneim.-Forsch., 36, 1733 (1986), Deyo, R.A., et al.: Science, 243, 809 (1989),<br></p>Formule :C21H26N2O8Couleur et forme :NeatMasse moléculaire :434.44Eltrombopag Olamine
CAS :<p>Stability Hygroscopic<br>Applications Eltrombopag is an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Bussel, J., et al.: New Eng. J. Med., 357, 2237 (2007), Marsilje, T., et al.: Bioorg. Med. Chem. Lett., 18, 5259 (2008), Alper, P., et al.: Bioorg. Med. Chem. Lett., 18, 5255 (2008)<br></p>Formule :C25H22N4O4·2C2H7NOCouleur et forme :Dark RedMasse moléculaire :564.631-(4-Chlorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)propane-1,3-dione
CAS :Degré de pureté :97.0%Masse moléculaire :262.690002441406254-hydrazinyl-1-methyl-1H-pyrazole dihydrochloride
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :185.0500030517578N-Boc-L-cis-4,5-Methanoprolineamide
CAS :Produit contrôlé<p>Applications N-Boc-L-cis-4,5-Methanoprolineamide is an intermediate used to prepare methanoprolinenitrile-contg. dipeptide mimetics as DPP-IV inhibitors and as antidiabetic agents.<br>References Magnin, D., et al.: J. Med. Chem., 47, 2587 (2004)<br></p>Formule :C11H18N2O3Couleur et forme :NeatMasse moléculaire :226.272(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran
CAS :Produit contrôlé<p>Applications (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran is used as a reactant in the efficient synthesis of empagliflozin inhibitor of SGLT-2 utilizing AlCl3-promoted silane reduction of β-glycopyranoside.<br>References Wang, X., et al.: Org. Lett., 16, 4090 (2014);<br></p>Formule :C17H16BrClO2Couleur et forme :Off-WhiteMasse moléculaire :367.66Rivastigmine-d4 Tartrate Salt
CAS :Produit contrôlé<p>Applications Rivastigmine-d4 Tartrate Salt, is the labeled analogue of Rivastigmine Tartrate Salt (R541000), a brain selective acetylcholinesterase inhibitor. Nootropic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Rosler, M., et al.: Brit. Med. J., 318, 633 (1999), Enz, A., et al.: Prog. Brain Res., 98, 431 (1993),<br></p>Formule :C18H24D4N2O8Couleur et forme :NeatMasse moléculaire :404.45Levetiracetam-d6
CAS :Produit contrôlé<p>Applications Levetiracetam-d6 is a labelled (S)-enantiomer of the ethyl analog of Piracetam (P500800), an anticonvulsant.<br>References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992), Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996), Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000),<br></p>Formule :C8D6H8N2O2Couleur et forme :NeatMasse moléculaire :176.253-Hydroxy Medetomidine
CAS :Produit contrôlé<p>Applications A metabolite of Medetomidine (M203250).<br>References Salonen, J.S., et al.: Xenobiotica, 20, 471 (1990),<br></p>Formule :C13H16N2OCouleur et forme :NeatMasse moléculaire :216.28Methylfelbamate
CAS :Produit contrôlé<p>Applications Methylfelbamate is a methyl impurity of felbamate (F231000), which is antiepileptic, structurally similar to meprobamate.<br>References Swinyard, E.A., et al.: Epilepsia, 27, 27 (1986), Remmel, R.P., et al.: Ther. Drug Monit., 12, 90 (1990), Sofia, R.D., et al.: Epilepsy Res. Suppl., 3, 103 (1991),<br></p>Formule :C12H16N2O4Couleur et forme :NeatMasse moléculaire :252.275-(CHLOROMETHYL)-3-(3-PHENOXYPYRIDIN-4-YL)-1,2,4-OXADIAZOLE
Degré de pureté :95.0%Masse moléculaire :287.700012207031255-Hydroxy Omeprazole Sodium Salt
CAS :<p>Stability Hygroscopic<br>Applications The main metabolite of Omeprazole.<br>References Renberg, L., et al.: Drug Metab. Dispos., 17, 69 (1989), Calabresi, L., et al.: Pharmacol. Res., 49, 493 (2004), Yin, O., et al.: J. Clin. Pharmacol., 44, 582 (2004),<br></p>Formule :C17H18N3NaO4SCouleur et forme :White To Light YellowMasse moléculaire :383.406-(3-methyl-1,2,4-oxadiazol-5-yl)quinoxaline
CAS :Degré de pureté :95.0%Masse moléculaire :212.21200561523438Methyl-1-naphthalenemethylamine
CAS :<p>Impurity Terbinafine EP Impurity A; Terbinafine BP Impurity A; Terbinafine USP Related Compound A<br>Applications Terbinafine EP Impurity A. Terbinafine BP Impurity A. Terbinafine USP Related Compound A<br></p>Formule :C12H13NCouleur et forme :OrangeMasse moléculaire :171.24Methyl 5-chloro-2-hydroxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate
CAS :Produit contrôlé<p>Applications Methyl 5-chloro-2-hydroxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (cas# 144172-24-7) is a useful research chemical. It is an intermediate in the synthesis of IN-KG 433 (I627995). IN-KG 433 is an impurity of Indoxacarb (I654000), an oxadiazine pesticide that acts against lepidopteran larvae and is the active ingredient in a number of household insecticides including cockroach baits.<br>References Wang, H., et al.: Water. Sci. Technol., 61, 2733 (2010); Shono, T., et al.: Pesticide. Biochem. Physiol., 75, 1 (2003);<br></p>Formule :C11H9O4ClCouleur et forme :NeatMasse moléculaire :240.632-((3-(4-Cyanonaphthalen-1-yl)pyridin-4-yl)thio)-N-(methylsulfonyl)acetamide 2,2,2-trifluoroacetate
Degré de pureté :97%Masse moléculaire :511.492-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)acetohydrazide
CAS :Degré de pureté :95.0%Masse moléculaire :253.61000061035156N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(piperazin-1-yl)propoxy)quinazolin-4-amine
CAS :Degré de pureté :97%Masse moléculaire :445.9200134277344(R)-Lisinopril Sodium Salt
CAS :<p>Applications R,S,S-Isomer of Lisinopril (L468985).<br>References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Formule :C21H31N3NaO5Couleur et forme :NeatMasse moléculaire :428.48Fenoterol-d6 Hydrobromide
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications Labelled Fenoterol (F248850). An β2-adrenergic agonist. Bronchodilator; tocolytic.<br>References Schuster, B., et al. Arzneim.-Forsch., 19, 1905 (1969), Gerris, J., et al.: Eur. J. Clin. Pharmacol., 18, 443 (1980), Heel, R.C., et al.: Drugs, 15, 3 (1978),<br></p>Formule :C17D6H15NO4·BrHCouleur et forme :Off White To BrownMasse moléculaire :390.304-piperazin-1-ylquinazoline
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :214.27200317382812Dihydro-Axitinib
CAS :<p>Applications Dihydro-Axitinib is a useful intermediate for the preparation of axitinib; an antitumor agent.<br>References Chekal, B. P., et al.: Org. Process Res. Dev., 18, 266 (2014)<br></p>Formule :C22H20N4OSCouleur et forme :White To Off-WhiteMasse moléculaire :388.494’-(Trifluoromethyl)valerophenone-(E)-O-2-(2-aminoethyl) Oxime Maleate
Produit contrôlé<p>Applications 4’-(Trifluoromethyl)valerophenone(E)-O-2-(2-aminoethyl) Oxime Maleate is an impurity in the synthesis of Fluvoxamine (F603500), a selective serotonin reuptake inhibitor (SSRI) used as an anti-depressant. Antiobsessional.<br>References Claassen, V., et al.: Br. J. Pharmacol., 60, 505 (1977), Koran, L.M., et al.: J. Clin. Psychopharmacol., 16, 121 (1996), Ware, M.R., et al.: J. Clin. Psychiatry, 58, Suppl. 5, 15 (1997), Inazu, M., et al.: Neurochem. Int., 39, 39 (2001)<br></p>Formule :C20H28F3N3O5Couleur et forme :NeatMasse moléculaire :447.454-Bromoquinoline-6-carbonitrile
CAS :Formule :C10H5BrN2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :233.0684'-O-Methylcatechin
CAS :<p>Applications A metabolite of (+)-Catechin, a major polyphenol in many fruits and vegetables.<br>References Heptinstall, S., et al.: J. Cardiovas. Pharmacol., 47, S197 (2006), Gonzalez-Manzano, S., et al.: J. Agric. Food Chem., 57, 1231 (2009), Frank, J., et al.: J. Nut., 139, 58 (2009),<br></p>Formule :C16H16O6Couleur et forme :NeatMasse moléculaire :304.29Darunavir-d9
CAS :Produit contrôlé<p>Applications Second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research product.<br>References Koh, Y., et al.: Antimicrob. Agents Chemother., 47, 3123 (2003), Arasteh, K., et al.: AIDS, 19, 943 (2005), Surleraux, D.L.N.G., et al.: J. Med. Chem., 48, 1813 (2005),<br></p>Formule :C272H9H28N3O7SCouleur et forme :Off-White To Light BeigeMasse moléculaire :556.72Indomethacin-d4
CAS :Produit contrôlé<p>Applications Nonsteroidal anti-inflammatory agent (NSAID).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Salari, H., et al.: Prostagland. Leukotrienes Med., 13, 53 (1984), Lehmann, J.M., et al.: J. Biol. Chem., 272, 3406 (1997)<br></p>Formule :C192H4H12ClNO4Couleur et forme :White To Off-WhiteMasse moléculaire :361.81Linagliptin Acetamide
CAS :Produit contrôlé<p>Impurity Linagliptin N-Acetyl Impurity<br>Applications Linagliptin Acetamide is an impurity of linagliptin (L465900), which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.<br>References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);<br></p>Formule :C27H30N8O3Couleur et forme :NeatMasse moléculaire :514.58
![Carvedilol N’-2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC184650.webp&w=3840&q=75)
![1,4-bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB426500.webp&w=3840&q=75)
![3-[(4-Fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FF595620.webp&w=3840&q=75)
![3,6-Bis(5-bromothiophen-2-yl)-2,5-dioctylpyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF694915.webp&w=3840&q=75)
![Tert-Butyl 1-oxo-4-(pyridin-3-yl)-2,8-diazaspiro[4.5]decane-8-carboxylate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF615325.webp&w=3840&q=75)
![2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD449705.webp&w=3840&q=75)
![[1-(2-Thienyl)-3,4-dihydroisoquinolin-2(1H)-yl]acetic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF494876.webp&w=3840&q=75)
![(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB680755.webp&w=3840&q=75)
